Arenicin-1 vs hGHRH(1-37)OH
Head-to-head comparison of Arenicin-1 (Arenicin-1) and hGHRH(1-37)OH (Human growth hormone-releasing factor (1-37) hydroxyl) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | hGHRH(1-37)OH |
|---|---|---|
| Category | Marine-Derived | Growth Hormone |
| Full Name | Arenicin-1 | Human growth hormone-releasing factor (1-37) hydroxyl |
| Molecular Weight | 2079 Da | N/A |
| Half-Life | n/a | 5-20 minutes |
| Amino Acids | 21 | 37 |
| Typical Dose | n/a | 1-2 mcg/kg |
| Route | preclinical | Subcutaneous/IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 60 |
| Research Status | Pre-clinical | Clinical Research |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
hGHRH(1-37)OH Benefits
- ✓GH release studies
- ✓minimal-sequence mapping
- ✓receptor pharmacology
- ✓peptide stability research
Arenicin-1 Dosing
bacterial infection|biofilm disruption
hGHRH(1-37)OH Dosing
1-2 mcg/kg SC or IV bolus|acute stimulation with serial GH assays|short-course research administration with biomarker monitoring
Arenicin-1 Side Effects
- ⚠Arenicola marina
hGHRH(1-37)OH Side Effects
- ⚠flushing
- ⚠headache
- ⚠transient fatigue
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
hGHRH(1-37)OH
Human GHRF(1-37)OH has appeared in studies examining how loss of C-terminal residues affects biological activity at the GHRH receptor. It is often used alongside other fragments to define structure-activity relationships within the GHRH family.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.